Effect of Sevelamer on Glucose Tolerance and Insulin Sensitivity in Patients With Chronic Renal Failure (CKD)
Status:
Withdrawn
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to perform a randomized, controlled clinical trial to
investigate if the phosphate binder sevelamer can improve insulin resistance and glucose
handling in patients receiving maintenance hemodialysis.